The Toronto Stock Exchange reports that Titan Medical Inc. will be delisted at the close on Oct. 15, 2024. According to the TSX, the company has completed an amalgamation involving Conavi Medical Inc., pursuant to an amalgamation agreement dated March 17, 2024, as amended, entered into between Conavi, the company and a wholly owned subsidiary of the company, 1000824255 Ontario Inc., which resulted in the reverse takeover of the company by Conavi.

Immediately prior to the closing of the amalgamation, the shares of Titan Medical were consolidated on a one-for-25 basis. Following completion of the amalgamation, Titan Medical changed its name to Conavi Medical Corp. In order to receive resulting issuer common shares on a postconsolidated basis, holders of shares of Titan Medical are asked to return the letter of transmittal along with share certificates and/or DRS advices to Computershare Trust Company of Canada at its principal office in Toronto. The TSX understands that shares of the resulting issuer will be listed on the TSX Venture Exchange under the symbol CNVI and will begin trading on Oct. 16, 2024.

For more information, see the joint information circular of the company and Conavi, dated Aug. 30, 2024, available on SEDAR+.